Threshold Pharmaceuticals (THLD)
News
| 12:29 AM | $THLD http://stks.co/43kr Watch break of $7.50; Nice volume over last few sessions by amitp_gupta |
| May 31 | @reuvenohr love this one long for past 5-6 months now, steamy Hot! $THLD by HighGrowthFinancial |
| May 31 | RT @HighGrowthFinancial $THLD buying pressure<-discussing it now in webinar by reuvenohr |
| May 31 | $THLD buying pressure by HighGrowthFinancial |
| May 31 | ASCO tomorrow..long $IMUC $ISR $THLD $GALE by elairet |
| May 31 | 2012's 2 Best Health-Care Stocks |
| May 31 | $THLD oops forget the chart http://chart.ly/vw3mi4k by woowtrading |
| May 31 | $THLD we are right at resistance we need to push little higher, or lose the war, The upper channel always tough to break. Check the chart by woowtrading |
| May 31 | Killing it on $IMUC and $THLD looks ready to bounce. by purist |
| May 31 | Nice movement on $THLD, still long. by TRNstocks |
| May 31 | Wall Street Loves These Stocks. Should You? |
| May 31 | 4 Highly Liquid Biotech Stocks With Bearish Short Trends |
| May 30 | Threshold Pharmaceuticals Announces Presentation and Webcast at Jefferies Global Heal... |
| May 29 | 2012's 2 Best Health-Care Stocks Fool |
Profile
Exchange: NASDAQCM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Threshold Pharmaceuticals is up 312.1% over the last year vs S&P 500 Total Return down 0.41%, Galena Biopharma down 5.00%, and BioDelivery Sciences International down 3.13%.
- THLD Total Returns
- ^SPXTR Total Returns
- GALE Total Returns
- BDSI Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these THLD related companies
Pro Strategies Featuring THLD
Did Threshold Pharmaceuticals make it into our Pro Portfolio Strategies?
THLD Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other THLD Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| THLD | 7.17 | -0.16 | -2.18% | 377.71M |
| THI | 52.16 | -1.14 | -2.14% | 8.441B |
| THG | 38.54 | -0.47 | -1.20% | 1.756B |
| SWM | 65.53 | -1.37 | -2.05% | 1.066B |
| SWKS | 26.11 | -0.75 | -2.79% | 5.061B |
| SWK | 64.46 | -1.79 | -2.70% | 11.29B |
| SWIR | 8.90 | -0.08 | -0.89% | 278.11M |
| SWI | 44.20 | -1.66 | -3.62% | 3.322B |
| SWHC | 6.53 | -0.21 | -3.12% | 437.22M |
| SWC | 8.44 | -0.05 | -0.59% | 981.78M |
